Cardinal Health (NYSE:CAH) Insider Michelle Greene Sells 11,650 Shares

Cardinal Health, Inc. (NYSE:CAH) insider Michelle Greene sold 11,650 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total value of $2,746,138.00. Following the completion of the transaction, the insider owned 10,330 shares in the company, valued at approximately $2,434,987.60. The trade was a 53.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Cardinal Health Trading Down 2.5%

Shares of Cardinal Health stock opened at $228.95 on Friday. The firm’s 50 day moving average is $231.91 and its 200 day moving average is $217.78. The firm has a market capitalization of $53.25 billion, a PE ratio of 31.67, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49. Cardinal Health, Inc. has a 1 year low of $145.87 and a 1 year high of $258.30.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. The business had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.Cardinal Health’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 28.49%.

Wall Street Analyst Weigh In

CAH has been the subject of several recent research reports. Wells Fargo & Company upped their price target on shares of Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. William Blair began coverage on Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating for the company. Robert W. Baird upped their target price on Cardinal Health from $251.00 to $274.00 and gave the company an “outperform” rating in a report on Wednesday, August 12th. Citigroup increased their target price on shares of Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Finally, Bank of America upped their price objective on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $266.56.

Hedge Funds Weigh In On Cardinal Health

Institutional investors have recently made changes to their positions in the stock. XML Financial LLC acquired a new stake in shares of Cardinal Health in the 2nd quarter valued at about $210,000. Laidlaw Wealth Management LLC boosted its holdings in Cardinal Health by 91.1% in the second quarter. Laidlaw Wealth Management LLC now owns 2,565 shares of the company’s stock worth $609,000 after acquiring an additional 1,223 shares in the last quarter. Symphony Financial Ltd. Co. boosted its holdings in Cardinal Health by 6.3% in the second quarter. Symphony Financial Ltd. Co. now owns 3,624 shares of the company’s stock worth $857,000 after acquiring an additional 214 shares in the last quarter. Lone Peak Global Investors LLC grew its stake in Cardinal Health by 6.1% in the second quarter. Lone Peak Global Investors LLC now owns 121,090 shares of the company’s stock valued at $28,766,000 after acquiring an additional 6,928 shares during the period. Finally, Investors Research Corp bought a new stake in shares of Cardinal Health during the second quarter valued at approximately $29,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Royal Bank of Canada initiated coverage of Cardinal Health with a “moderate buy” or outperform-equivalent rating. RBC cited the integration of higher-margin services as a potential driver of future earnings outperformance. RBC Capital Starts Cardinal Health at Outperform
• Positive Sentiment: A Zacks analysis identified CAH as a potentially attractive long-term value stock, while recent coverage has highlighted Cardinal Health’s precision-medicine operations and higher-margin services as sources of sustained growth. Why Cardinal Health Is a Top Value Stock for the Long-Term
• Neutral Sentiment: Brokerages continue to assign Cardinal Health a consensus “moderate buy” rating. The constructive view is tempered by valuation and questions about the sustainability of recent earnings gains.
• Negative Sentiment: Multiple executives and insiders sold shares around $235–$237. Chief Executive Officer Jason Hollar sold a combined 124,529 shares worth approximately $29.4 million, while CEO Deborah Weitzman sold about $1.7 million. Other insider sales included Chief Accounting Officer Mary Scherer and executives Michelle Greene, Jessica Mayer, and Stephen Mason. The transactions substantially reduced several executives’ holdings and may signal that insiders are taking profits after the stock’s strong rally. Cardinal Health Insider Sale Filing
• Negative Sentiment: Although Cardinal Health reported adjusted quarterly EPS of $2.91, well above the $2.42 consensus, an analysis noted that a significant portion of the earnings improvement came from a one-time tariff refund. That raises concerns about the durability of the earnings beat and may be contributing to the weaker stock performance. Cardinal Health Earnings Analysis

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.